Targeted Oncology5h
Behind Durvalumab's FDA Approval: NIAGARA Trial in MIBC
Matt Galsky, MD, discusses the phase 3 NIAGARA trial that led to the recent FDA approval of durvalumab in muscle-invasive ...
A New ‘Friday’ Movie, ‘Conjuring’ Phase Two, and Surviving Corporate Merger Hell: A Chat with New Line Boss Richard Brener
Bonus: a lightning round of which titles could be coming back. Never say never on more 'Mask' and 'Snakes on a Plane' but don ...